Illumina ILMN
NASDAQ ILMN
$245.18 +16.25 (+7.10%)
At close: Sep 17, 2026 · 4:00 PM EDT

Illumina (ILMN) Cash from Financing Activities (2009 - 2026)

Illumina's (ILMN) quarterly Cash from Financing Activities came in at -$129.0 million in Q2 2026, up 65.23% on a YoY basis from -$78.1 million in Q2 2025, and up 48.61% quarter-over-quarter from -$251.0 million in Q1 2026.

Analysis

Illumina (ILMN) Cash from Financing Activities (2009 - 2026) Analysis & Trends

Illumina (ILMN) has reported Cash from Financing Activities for 18 consecutive years, with -$129.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Cash from Financing Activities rose 65.23% year-over-year to -$129.0 million; the trailing twelve-month figure through Jun 2026 stood at -$558.0 million (up 40.95% YoY), and the FY2025 full-year result was -$744.0 million, down 30.53% from the prior year.
  • Cash from Financing Activities improved to -$129.0 million in Q2 2026 per ILMN's latest filing, from -$251.0 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $922.0 million in Q1 2023 and bottomed at -$707.0 million in Q4 2023.
  • Historically, Cash from Financing Activities has averaged -$122.6 million across 5 years, with a median of -$122.0 million in 2025.
  • The widest YoY moves for Cash from Financing Activities: up 107.4% in 2024, down 7433.33% in 2024.
  • Over 5 years, Cash from Financing Activities stood at $21.0 million in 2022, then plunged by 228.57% to -$27.0 million in 2023, then sank by 74.07% to -$47.0 million in 2024, then tumbled by 34.04% to -$63.0 million in 2025, then tumbled by 104.76% to -$129.0 million in 2026.
  • According to Business Quant data, Cash from Financing Activities over the past three periods registered -$129.0 million, -$251.0 million, and -$63.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn -1.57 Bn
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn 7.27 Bn
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn 471.00 Mn
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn -129.00 Mn
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn -23.16 Mn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn -33.21 Mn
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn -27.60 Mn
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn -6.20 Mn
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn 3.02 Mn
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn 149.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 -129.00 Mn
Mar 29, 2026 -251.00 Mn
Dec 28, 2025 -63.00 Mn
Sep 28, 2025 -115.00 Mn
Jun 29, 2025 -371.00 Mn
Mar 30, 2025 -195.00 Mn
Dec 29, 2024 -47.00 Mn
Sep 29, 2024 -332.00 Mn
Jun 30, 2024 -226.00 Mn
Mar 31, 2024 35.00 Mn
Dec 31, 2023 -27.00 Mn
Oct 1, 2023 -707.00 Mn
Jul 2, 2023 -3.00 Mn
Apr 2, 2023 -473.00 Mn
Jan 1, 2023 922.00 Mn
Apr 3, 2022 21.00 Mn
Oct 3, 2021 -394.00 Mn
Jul 4, 2021 -496.00 Mn
Apr 4, 2021 968.00 Mn
Jan 3, 2021 -331.00 Mn